Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Unwanted Facial Hair Growth from Oral Minoxidil

Risk Profile and Incidence

  • A Brazilian cohort of 435 patients receiving low-dose oral minoxidil (LDOM) ≤5 mg/day for androgenetic alopecia confirmed similar tolerability patterns, with unwanted hair growth affecting approximately 15% of patients 1, 2

Mechanism and Management

Management Strategies

Clinical Pearls